PMC:7594251 / 11007-11186
Annnotations
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T71596 | 63-65 | http://purl.obolibrary.org/obo/CL_0000453 | denotes | LC |
| T60852 | 68-70 | http://purl.obolibrary.org/obo/CLO_0007874 | denotes | MS |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T67 | 63-65 | Chemical | denotes | LC | http://purl.obolibrary.org/obo/CHEBI_73582 |
| T68 | 68-70 | Chemical | denotes | MS | http://purl.obolibrary.org/obo/CHEBI_73613 |
| T69 | 139-148 | Chemical | denotes | molecules | http://purl.obolibrary.org/obo/CHEBI_25367 |
| T70 | 158-163 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T76 | 0-179 | Sentence | denotes | Corcoran and Spraul [98] emphasize that liquid chromatography (LC), MS, and NMR utilized in parallel give comprehensive structural data on molecules of novel drugs in development. |